Laitinen J T, Laitinen K S, Tuomisto L, Airaksinen M M
Department of Physiology, University of Kuopio, Finland.
Brain Res. 1994 Dec 30;668(1-2):117-21. doi: 10.1016/0006-8993(94)90517-7.
A microdialysis method combined with a sensitive radioimmunoassay was used to monitor extracellular cyclic GMP (cGMP) levels in the frontal cortex and the cerebellum of anesthetized rats in vivo. Basal cGMP release remained constant throughout the perfusion period and was approximately 2 fmol/30 min in the frontal cortex and approximately 4 fmol/30 min in the cerebellum. The nitric oxide (NO) donor sodium nitroprusside (SNP) stimulated cGMP release transiently in both regions. However, the maximal response was 3-fold in the frontal cortex (obtained with 5 microM SNP) but 90-fold in the cerebellum (obtained with 1 mM SNP). Perfusion with the NO synthase (NOS) inhibitor NG-nitro-L-arginine methyl ester (L-NAME) suppressed cerebellar cGMP release by 74% indicating that NO is the major regulator of basal cGMP levels in the cerebellum. Quite opposite, L-NAME exhibited no potency in the frontal cortex suggesting that other activators of guanylyl cyclase may regulate basal cortical cGMP levels in vivo.
采用微透析法结合灵敏的放射免疫分析法,在体内监测麻醉大鼠额叶皮质和小脑中细胞外环磷酸鸟苷(cGMP)水平。在整个灌注期,基础cGMP释放保持恒定,额叶皮质约为2 fmol/30分钟,小脑约为4 fmol/30分钟。一氧化氮(NO)供体硝普钠(SNP)在两个区域均短暂刺激cGMP释放。然而,额叶皮质的最大反应为3倍(用5 microM SNP获得),而小脑为90倍(用1 mM SNP获得)。用一氧化氮合酶(NOS)抑制剂NG-硝基-L-精氨酸甲酯(L-NAME)灌注可使小脑cGMP释放减少74%,表明NO是小脑中基础cGMP水平的主要调节因子。相反,L-NAME在额叶皮质无作用,提示鸟苷酸环化酶的其他激活剂可能在体内调节基础皮质cGMP水平。